{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To accelerate recovery from acute optic neuritis and motor symptoms Standard of care for disabling demyelinating relapse\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection required during high-dose steroid therapy\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Must await confirmation of diagnosis (MS vs NMO vs MOGAD) Requires assessment of McDonald criteria for dissemination in time\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To accelerate recovery from acute optic neuritis and motor symptoms\", \"Standard of care for disabling demyelinating relapse\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection required during high-dose steroid therapy\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Must await confirmation of diagnosis (MS vs NMO vs MOGAD)\", \"Requires assessment of McDonald criteria for dissemination in time\"]}]"
}